Skip to main content
SpringerLink
Log in

Identifying and Validating Causal Genetic Alterations in Human Breast Cancer

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

An important mechanism for the activation of proto-oncogenes in human breast and other cancers is gene amplification, which results in gene overexpression at both the message and the protein levels. Recent studies have demonstrated that oncogenes rarely if ever become amplified in isolation, but rather are present on large amplicons that contain multiple genes. More detailed analysis of these amplicons has revealed the presence of many candidate breast cancer oncogenes. The broad goal of this issue of Breast Cancer Research and Treatment is to review the current state of our understanding of the causal role of defined genetic alterations that occur in human breast cancers, and to discuss the case for the mechanistic significance of several candidate oncogenes. As will be seen, these studies have revealed a remarkable genetic complexity and heterogeneity in human breast cancer that must be dissected in order to improve our mechanistic understanding of disease progression, and to develop effective new drugs against relevant molecular targets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ethier SP: Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst 87: 964-973, 1995

    Google Scholar 

  2. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL: Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182, 1987

    Google Scholar 

  3. Borg A, Tandon AK, Sigurdsson H, Clark GM, Ferno M, Fuqua SAW, Killander D, McGuire WL: HER-2/neu ampli-fication predicts poor survival in node-positive breast cancer. Cancer Res 50: 4332-4337, 1990

    Google Scholar 

  4. Woods Ignatoski KM, LaPointe AJ, Radany EH, Ethier SP: ErbB-2 overexpression in human mammary epithelial cells confers growth factor independence. Endocrinology 140: 3615-3622, 1999

    Google Scholar 

  5. Woods Ignatoski KM, Maehama T, Markwart SM, Dixon JE, Livant DL, Ethier SP: ErbB-2 overexpression confers PI 3_-kinase-dependent invasion capacity on human mammary epithelial cells. Br J Cancer 82: 666-674, 2000

    Google Scholar 

  6. Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P: Singlestep induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54: 105-115, 1988

    Google Scholar 

  7. Siegel PM, Dankort DL, Hardy WR, Muller WJ: Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors. Mol Cell Biol 14: 7068-7077, 1994

    Google Scholar 

  8. Leyland-Jones B, Smith I: Role of herceptin (r) in primary breast cancer: views from North America and Europe. Oncology 61: 83-91, 2001

    Google Scholar 

  9. Spiridon CI, Ghetie MA, Uhr J, Marches R, Li JL, Shen GL, Vitetta ES: Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity of a human breast cancer cell line in vitro and in vivo. Clinical Cancer Res 8: 1720-1730, 2002

    Google Scholar 

  10. Jarvinen TA, Tanner M, Rantanen V, Barlund M, Borg A, Grenman S, Isola J: Amplification and deletion of topoisomerase II alpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer. Am J Pathol 156: 839-847, 2000

    Google Scholar 

  11. Fiddes RJ, Campbell DH, Janes PW, Sivertsen SP, Sasaki H, Wallasch C, Daly RJ: Analysis of Grb7 recruitment by heregulin-activated ErbB receptors reveals a novel target selectivity for ErbB3. J Biol Chem 273: 7717-7724, 1998

    Google Scholar 

  12. Han DC, Shen TL, Guan JL: Role of Grb7 targeting to focal contacts and its phosphorylation by focal adhesion kinase in regulation of cell migration. J Biol Chem 275: 28911-28917, 2000

    Google Scholar 

  13. Tanaka S, Sugimachi K, Kawaguchi H, Saeki H, Ohno S, Wands JR: Grb7 signal transduction protein mediates metastatic progression of esophageal carcinoma. J Cell Physiol 183: 411-415, 2000

    Google Scholar 

  14. Woods Ignatoski K, Ethier SP: Constitutive activation of pp 125fak in eleven newly isolated breast cancer cell lines. Breast Cancer Res Treatment 54: 173-182, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Division of Radiation and Cancer Biology, The University of Michigan Health System, and the University of Michigan Comprehensive Cancer Center, Ann Arbor, MI, USA

    Stephen P. Ethier

Authors
  1. Stephen P. Ethier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ethier, S.P. Identifying and Validating Causal Genetic Alterations in Human Breast Cancer. Breast Cancer Res Treat 78, 285–287 (2003). https://doi.org/10.1023/A:1023078722316

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023078722316

Search

Navigation